PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Immune protein could stop diabetes in its tracks

2013-05-20
(Press-News.org) Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.

The discovery has wider repercussions, as the protein is responsible for protecting the body against excessive immune responses, and could be used to treat, or even prevent, other immune disorders such as multiple sclerosis and rheumatoid arthritis.

Professor Len Harrison, Dr Esther Bandala-Sanchez and Dr Yuxia Zhang led the research team from the Walter and Eliza Hall Institute that identified the immune protein CD52 as responsible for suppressing the immune response, and its potential for protecting against autoimmune diseases. The research was published today in the journal Nature Immunology.

So-called autoimmune diseases develop when the immune system goes awry and attacks the body's own tissues. Professor Harrison said CD52 held great promise as a therapeutic agent for preventing and treating autoimmune diseases such as type 1 diabetes.

"Immune suppression by CD52 is a previously undiscovered mechanism that the body uses to regulate itself, and protect itself against excessive or damaging immune responses," Professor Harrison said. "We are excited about the prospect of developing this discovery to clinical trials as soon as possible, to see if CD52 can be used to prevent and treat type 1 diabetes and other autoimmune diseases. This has already elicited interest from pharmaceutical companies."

Type 1 diabetes is an autoimmune disease that develops when immune cells attack and destroy insulin-producing beta cells in the pancreas. Approximately 120,000 Australians have type 1 diabetes and incidence has doubled in the last 20 years. "Type 1 diabetes is a life-long disease," Professor Harrison said. "It typically develops in children and teenagers, and it really makes life incredibly difficult for them and their families. It also causes significant long-term complications involving the eyes, kidneys and blood vessel damage, and at great cost to the community."

Professor Harrison said that T cells that have or release high levels of CD52 are necessary to maintain normal balance in the immune system. "In a preclinical model of type 1 diabetes, we showed that removal of CD52-producing immune cells led to rapid development of diabetes. We think that cells that release CD52 are essential to prevent the development of autoiummune disease, and that CD52 has great potential as a therapeutic agent," he said.

CD52 appears to play a dominant role in controlling or suppressing immune activity in the early stages of the immune response, Professor Harrison said. "We identified a specialised population of immune cells (T cells) that carry high levels of CD52, which they release to dampen the activity of other T cells and prevent uncontrolled immune responses," Professor Harrison said. "The cells act as an early 'braking' mechanism."

Professor Harrison said his goal is to prevent and ultimately cure type 1 diabetes. "In animal models we can prevent and cure type 1 diabetes," Professor Harrison said. "I am hopeful that these results will be translatable into humans, hopefully in the not-too-distant future."



INFORMATION:



The research was supported by the National Health and Medical Research Council of Australia and the Victorian Government.



ELSE PRESS RELEASES FROM THIS DATE:

Competition in the quantum world

2013-05-20
This news release is available in German. "When water boils, its molecules are released as vapor. We call this change of the physical state of matter a phase transition," explains Sebastian Diehl from the Institute of Theoretical Physics at the University of Innsbruck. Together with his colleagues from the Institute for Experimental Physics and the theorist Markus Mueller from the Complutense University of Madrid, he studied the transition between two quantum mechanical orders in a way never before observed. The quantum physicists in Innsbruck use a new device ...

Diabetes drug tested in Parkinson's disease patients

2013-05-20
Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control. Despite intensive research, there are currently no approved therapies that have been demonstrated to alter the progression of the disease. In this issue of the Journal of Clinical Investigation, Dr. Thomas Foltynie and colleagues at the National Hospital for Neurology and Neurosurgery in London investigated the use of a drug approved for diabetes care, Exenatide, in PD patients. PD patients were divided into two groups: 20 patients received Exenatide injections ...

Women with severe injuries are less likely than men to be treated in a trauma center

2013-05-20
ATS 2013, PHILADELPHIA - Women are less likely than men to receive care in a trauma center after severe injury, according to a new study of almost 100,000 Canadian patients. "Gender-based disparities in access to healthcare services in general have been recognized for some time and evidence is emerging that these disparities extend to the treatment of severe injuries in trauma centers," says lead author Andrea Hill. MSc, PhD, a post-doctoral fellow at Sunnybrook Health Sciences Centre and the University of Toronto in Ontario, Canada. "Our study confirms and expands on ...

Source of infection affects hospital mortality in septic shock patients in the ICU

2013-05-20
In ICU patients who have septic shock, the anatomic source of infection has a strong effect on the chances of survival, according to a new study from researchers in Canada. "Understanding the local infection source in patients with septic shock may influence treatment strategies and clinical outcomes," said researcher Peter Dodek, MD MHSc, professor of critical care medicine at the University of British Columbia in Vancouver. "Accordingly, we examined the relationship between anatomic source of infection and hospital mortality in nearly 8,000 patients who had septic ...

New study identifies risk factors for depression among COPD patients

2013-05-20
ATS 2013, PHILADELPHIA ─ Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall healthcare burden for the COPD population. Now, a study from researchers in Argentina indicates female COPD patients and patients who experience significant shortness of breath may have the greatest risk for developing depression. The results of the study will be presented at the ATS 2013 International Conference. "About ...

Stress test may help predict increased mortality risk in sleep apnea patients

2013-05-20
ATS 2013, PHILADELPHIA – Many studies have shown that men and women who suffer from obstructive sleep apnea (OSA) - a disorder that causes breathing to halt intermittently during sleep – have a higher mortality rate than those who do not have the disorder. Now, a study from researchers at the Cleveland Clinic shows that OSA patients who also have poor functional capacity have an even greater risk of mortality and suggests that an assessment of functional capacity in this population can help physicians identify patients most at risk for death. The results of the study ...

Metabolic biomarkers can predict mortality in the ICU

2013-05-20
ATS 2013, PHILADELPHIA – A metabolic profile of intensive care unit (ICU) patients based on biomarkers of four metabolites can be used to accurately predict mortality, according to a new study. "Existing models for predicting mortality in the ICU may not always be accurate and they can also be cumbersome to use," said researcher Angela J. Rogers MD, MPH, Instructor in Medicine at Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School in Boston. "Levels of lactate, a metabolite from the carbohydrate pathway, are an established biomarker for ICU mortality. ...

Food laboratory accuracy remains a concern

2013-05-20
Food microbiology laboratories continue to submit false negative results and false positive results on a routine basis. A retrospective study of nearly 40,000 proficiency test results over the past 14 years, presented today at the 113th General Meeting of the American Society for Microbiology, examined the ability of food laboratories to detect or rule out the presence of Escherichia coli O157:H7, Salmonella, Listeria monocytogenes, and Campylobacter. "There is concern when laboratories report that pathogens are not found in a food sample, when in fact they are there," ...

Pharmaceutical advances offer new options for health outcomes

2013-05-20
Orlando, FL (May 20, 2013) — Research presented at Digestive Disease Week® (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C. An international study holds promising results for patients suffering from IBS-D. In the phase II study, researchers found that the drug ibodutant significantly improved symptoms in more than 50 percent of the individuals treated. "While there's been a lot of progress in medicines for IBS with constipation, we haven't seen the same in IBS with diarrhea," said Jan Tack, MD, professor ...

Mayo Clinic: Inflammatory bowel disease raises risk of melanoma

2013-05-20
ROCHESTER, Minn. — Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. The findings were presented at the Digestive Disease Week 2013 conference in Orlando, Fla. More than 1.5 million Americans have Crohn's disease or ulcerative colitis (UC), the most common forms of inflammatory bowel disease. Both conditions inflame the lining of the intestine, leading to bouts of watery diarrhea, rectal bleeding, ...

LAST 30 PRESS RELEASES:

Loneliness predicts poor mental and physical health outcomes

Keeping the photon in the dark

FDA-approved drugs could make nano-medicine safer, study finds

Many seafloor fish communities are retaining their individuality despite human impacts

Somali women’s perspectives on female genital mutilation and its abandonment

Structure of tick-borne virus revealed at atomic resolution for the first time

The robot will see you now

Stepping up the potential of wearables: predicting pediatric surgery complications

Prenatal and childhood lead exposure linked to faster memory decay in children

Medical needles in the hands of AI

Source criticism in school requires more than isolated interventions

Mount Sinai’s Andy Jagoda, MD, receives top honor from New York chapter of the American College of Emergency Physicians

Clinical trials reveal promising alternatives to highly toxic tuberculosis drug

Vanderbilt Health at forefront of improving head and neck surgery with fluorescence imaging to ‘light up’ nerves

Koalas spend only 1% of their life on the ground – but it’s killing them

Moon-Rice: Developing the perfect crop for space-bases

Forum with alcohol industry ties shows significant bias in reviews of health research

Underestimated sources of marine pollution

IPK research team unlocks potential of barley’s closest wild relative, Hordeum bulbosum

Study reveals the hidden benefits of weight loss on fat tissue

Gut microbes key to understanding how exercise boosts cancer immunity

Morning vs bedtime dosing and nocturnal blood pressure reduction in patients with hypertension

BMI in children before, during, and after the COVID-19 pandemic

Branching out: Tomato genes point to new medicines

Charité study analyzes 400 million years of enzyme evolution

Large-scale DNA study maps 37,000 years of disease history

Results from largest review of its kind on antidepressant withdrawal symptoms

Twist to the M-ax(is): New twist platform opens path to quantum simulation of more exotic states of matter

Chang'e-6 samples unlock secrets of the Moon’s farside

Teaching lasers to self-correct in high-precision patterned laser micro-grooving

[Press-News.org] Immune protein could stop diabetes in its tracks